Meridian Co., Ltd.
OTC Bulletin Board : MRDAF

Meridian Co., Ltd.

September 21, 2005 09:00 ET

Meridian Signs Letter of Intent with Morningstar Minerals

VANCOUVER, BRITISH COLUMBIA--(CCNMatthews - Sept. 21, 2005) - Meridian Co. Ltd. ("Meridian") (OTCBB:MRDAF), is pleased to announce it has signed a Letter of Intent with Morningstar Minerals.

The Letter of Intent states that Morningstar Minerals will purchase a minimum of 200 units of the Digital Pulse Analyzer within the next 12 months. The effect on Meridian with respect to the execution of a definitive agreement would be an increase in overall gross revenues for the remainder of 2005 with continued growth into 2006. Revenues will be realized immediately upon delivery of the initial Digital Pulse Analyzer units.

Meridian and Morningstar initially met at the 2004 American Naturopathic Medical Association conference and trade show in Las Vegas. Since that time, the two companies have worked together at various events to promote preventative health and wellness further enhancing their corporate synergies.

Meridian believes Morningstar's product line is exceptional and a leader in their target market. Their newest product "Got Arginine" an L-Arginine based product which uses their proprietary fulvic and humic acid delivery system allows the body to fully and quickly absorb this amino acid supplement. Arginine increases nitric oxide in the endothelial lining of arteries which makes the vessels relax, thus naturally reducing blood pressure and ultimately reducing the risk of heart disease. Nitric Oxide research won the 1998 Nobel Prize in medicine.

Meridian's FDA approved, non-invasive DPA is a perfect fit with Morningstar's product as it has progressed to become a proven method of detecting whether a particular treatment option, such as natural supplementation, is effective. Meridian is looking forward to a long and rewarding relationship with Morningstar.


Morningstar is centered on the vision of its founder and President Geoff McMahon. Geoff observed in his early years in Australia that minor amendments to minerals deficient soils had major results in the crops grown and to the consumers of these crops.

USDA studies show a 25-80% decline in minerals in the foods we eat. The human body needs a constant source of hydrogen, oxygen, minerals, trace elements, enzymes, and amino acids to repair and properly maintain itself. Our present food supplies are woefully inadequate at delivering these essential life sustaining compounds. Without hydrogen, oxygen & minerals we cannot exist.

Morningstar Minerals provides one of the best sources of organic, bio-available minerals, amino acids and trace elements available today. Their line of products contain high levels of organic, bio available Humic and Fulvic acid, the two essential compounds that result from nature's own process of recycling the elements of life.

Humic and Fulvic acid have been found to play an important role in cell metabolism, acting as carriers of essential nutrients into and metabolic wastes out of the cell. They also act to convert some waste products into useful materials within the cell.


Meridian is an established leader in the research/development, manufacturing, and sales of integrative medical diagnostic equipment. The company sells its products and equipment to a wide array of customers in the global health care industry. The company presently holds a total of 18 worldwide patents on its technology, and has received FDA, as well as other international regulatory approvals for many of its products.

Meridian is committed to the ongoing global research and advancement of integrative medical products that contribute to the better health of humanity.

On Behalf of the Board of Directors,

Hyeon Seong Myeong, President

This press release may contain certain forward-looking information and statements concerning the company's operations, performance and financial condition. These statements are based upon a number of uncertainties and contingencies, many of which are beyond the control of the company. Actual results may differ materially from those expressed or implied by such forward-looking statements. This document is not intended to be and is not an advertisement for any securities of the company.

Contact Information